(BAXTER) VIAFLO HARTMANN (RINGER LACTATE) Solution for Intravenous Infusion

What is (BAXTER) VIAFLO HARTMANN (RINGER LACTATE)

(BAXTER) VIAFLO HARTMANN (RINGER LACTATE) is a sterile, non-pyrogenic solution for intravenous infusion. It is commonly used for fluid and electrolyte replenishment in patients requiring parenteral therapy. The solution is composed of:

• Sodium Chloride: 6.0 g/L
• Potassium Chloride: 0.4 g/L
• Calcium Chloride Dihydrate: 0.27 g/L
• Sodium Lactate: 3.2 g/L

This composition closely resembles the electrolyte concentration of plasma, making it suitable for restoring fluid balance and correcting electrolyte deficiencies.

How to use (BAXTER) VIAFLO HARTMANN (RINGER LACTATE)

Administration should be under the supervision of a healthcare professional. Key considerations include:

• Route: Intravenous infusion using aseptic technique.
• Dosage: Determined based on patient’s age, weight, clinical condition, and laboratory results.
• Monitoring: Regular assessment of fluid balance, electrolyte levels, and acid-base status.
• Compatibility: Do not mix with blood products or incompatible drugs.

Ensure the solution is clear and the container is intact before use. Discard any unused portion.

Mode of Action (BAXTER) VIAFLO HARTMANN (RINGER LACTATE)

The solution works by replenishing fluids and electrolytes. Each component serves a specific function:

• Sodium and Chloride: Maintain osmotic balance and extracellular fluid volume.
• Potassium: Essential for cellular function and nerve impulse transmission.
• Calcium: Crucial for muscle contraction and blood coagulation.
• Lactate: Metabolized to bicarbonate, aiding in correcting metabolic acidosis.

This balanced electrolyte composition helps restore normal physiological functions in patients with fluid and electrolyte imbalances.

(BAXTER) VIAFLO HARTMANN (RINGER LACTATE) Interactions (BAXTER) VIAFLO HARTMANN (RINGER LACTATE)

Potential drug interactions include:

• Digitalis Glycosides: Increased risk of arrhythmias due to calcium content.
• Potassium-Sparing Diuretics: Risk of hyperkalemia.
• ACE Inhibitors and ARBs: May elevate potassium levels.
• Blood Products: Calcium may cause coagulation; avoid co-administration.

Always consult with a healthcare provider before combining with other medications.

Dosage of (BAXTER) VIAFLO HARTMANN (RINGER LACTATE)

Dosage should be individualized:

• Adults: Typically 25-30 mL/kg/day, adjusted based on clinical needs.
• Children: Based on body weight and clinical condition.
• Maximum Rate: Depends on patient’s cardiovascular status and fluid requirements.

Continuous monitoring is essential to avoid fluid overload and electrolyte imbalances.

Possible side effects of (BAXTER) VIAFLO HARTMANN (RINGER LACTATE)

Potential adverse effects include:

• Fluid Overload: Leading to edema or pulmonary congestion.
• Electrolyte Imbalances: Such as hyperkalemia or hypercalcemia.
• Metabolic Alkalosis: Due to lactate metabolism.
• Local Reactions: Pain or inflammation at the infusion site.

Report any unusual symptoms to a healthcare provider promptly.

(BAXTER) VIAFLO HARTMANN (RINGER LACTATE) Contraindications (BAXTER) VIAFLO HARTMANN (RINGER LACTATE)

Do not use in patients with:

• Hyperkalemia: Elevated potassium levels.
• Hypercalcemia: High calcium levels.
• Severe Renal Impairment: Risk of fluid and electrolyte accumulation.
• Lactic Acidosis: May exacerbate the condition.
• Concomitant Blood Transfusion: Risk of coagulation due to calcium content.

Always assess patient history before administration.

Storage of (BAXTER) VIAFLO HARTMANN (RINGER LACTATE)

Proper storage ensures efficacy and safety:

• Temperature: Store at room temperature (25°C/77°F); brief exposure up to 40°C/104°F is acceptable.
• Light: Keep away from direct sunlight.
• Container Integrity: Do not use if the solution is discolored or the container is damaged.
• Shelf Life: Refer to the manufacturer's guidelines for expiration date.

Ensure the solution is used before the expiration date and stored under recommended conditions.